Xoma | XOMA - Passifs Courants





Passifs Courants Changement Date
AbbVie USD 43.29B 3.9B 2025-12
Agenus USD 323.49M 36.36M 2025-12
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Ardelyx USD 109.57M 20.96M 2026-03
aTyr Pharma USD 113.19M 97.51M 2025-12
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Celldex Therapeutics USD 50.99M 4.53M 2025-12
Curis USD 14.08M 5.3M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Incyte USD 1.49B 25.52M 2026-03
MacroGenics USD 43.11M 1.36M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 34.35B 2.64B 2026-03
Prothena USD 40.84M 10.59M 2025-12
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Xoma USD 28.3M 6.81M 2025-09